Fast, long-term relief from opioid dependence?

This week, the FDA could approve Braeburn Pharmaceuticals' buprenorphine implant, which provides up to six months continuous treatment for the withdrawal symptoms and cravings of opioid dependence.
This week, the FDA could approve Braeburn Pharmaceuticals' buprenorphine implant, which provides up to six months continuous treatment for the withdrawal symptoms and cravings of opioid dependence.

Could this implant be the new weapon against opioid, heroin addiction?

May 24, 2016 05:02 PM